Analyst Ratings for Solazyme (SZYM) [Buys]
SZYM Rating Summary
SZYM Price Target Summary
- Highest: $23.00 (Jefferies)
- Lowest: $10.00 (Piper Jaffray)
- Average: $16.25
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$16.25 (+48.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/19/2013 | Morgan Stanley | New Coverage | Overweight (N/A) |
15.00 (N/A) |
7.51 | 10.95 | 45.81% | Details |
| 1/30/2013 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
7.28 | 10.95 | 50.41% | Details |
| 8/13/2012 | Raymond James | Upgrade | Outperform (Market Perform) |
N/A (N/A) |
11.84 | 10.95 | -7.52% | Details |
| 6/21/2012 | ThinkEquity | New Coverage | Buy (N/A) |
15.00 (N/A) |
12.84 | 10.95 | -14.72% | Details |
| 6/12/2012 | UBS | New Coverage | Buy (N/A) |
16.00 (N/A) |
12.10 | 10.95 | -9.5% | Details |
| 5/16/2012 | Credit Suisse | New Coverage | Outperform (N/A) |
17.00 (N/A) |
9.92 | 10.95 | 10.38% | Details |
| 2/15/2012 | Canaccord Genuity » Updated 2/22/2012 |
New Coverage | Buy (N/A) |
19.00 (N/A) |
11.25 | 10.95 | -2.67% | Details |
| 7/6/2011 | Pacific Crest | New Coverage | Outperform (N/A) |
N/A (N/A) |
24.50 | 10.95 | -55.31% | Details |
| 7/6/2011 | Lazard Capital | New Coverage | Buy (N/A) |
N/A (N/A) |
24.50 | 10.95 | -55.31% | Details |
| 7/6/2011 | Jefferies » Updated 11/15/2012 |
New Coverage | Buy (N/A) |
23.00 (22.00) |
24.50 | 10.95 | -55.31% | Details |
| 7/6/2011 | Goldman Sachs » Updated 2/21/2013 |
New Coverage | Buy (N/A) |
15.00 (17.00) |
24.50 | 10.95 | -55.31% | Details |
